Leucovorin

Janessa Smith, Pharm.D., BCPS, Paul A. Pham, Pharm.D.

Leucovorin is a topic covered in the Johns Hopkins HIV Guide.

To view the entire topic, please log in or purchase a subscription.

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

Monkeypox

Coronavirus COVID-19 (SARS-CoV-2)

Suicide Risk in the COVID-19 Pandemic

Moderna COVID-19 Vaccine

BNT162b2 COVID-19 Vaccine (BioNTech/Pfizer)

Managing Stress and Coping with COVID-19

Johnson & Johnson COVID-19 Vaccine

-- The first section of this topic is shown below --

INDICATIONS

FDA

Prophylaxis for drug-induced bone marrow toxicity (e.g methotrexate, pyrimethamine, or trimethoprim)
Antidote to the toxic effects of folic acid antagonists such as methotrexate, pyrimethamine, and trimethoprim.
Megaloblastic anemias associated with sprue, nutritional deficiency, pregnancy, and infancy when oral folic acid therapy cannot be given.

-- To view the remaining sections of this topic, please log in or purchase a subscription --

INDICATIONS

FDA

Prophylaxis for drug-induced bone marrow toxicity (e.g methotrexate, pyrimethamine, or trimethoprim)
Antidote to the toxic effects of folic acid antagonists such as methotrexate, pyrimethamine, and trimethoprim.
Megaloblastic anemias associated with sprue, nutritional deficiency, pregnancy, and infancy when oral folic acid therapy cannot be given.

There's more to see -- the rest of this entry is available only to subscribers.